COVID-19: J&J announces vaccine candidate, Synairgen commences dosing

31st March 2020 Uncategorised 0

Sense Biodetection has also pitched in, announcing an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for the novel virus.

More: COVID-19: J&J announces vaccine candidate, Synairgen commences dosing
Source: News